Envestnet Asset Management Inc Axsome Therapeutics, Inc. Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 20,082 shares of AXSM stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,082

Previous 20,668 2.84%

Holding current value

$2.09 Million

Previous $1.66 Million 8.48%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$78.93 - $95.84 $46,252 - $56,162	-586 Reduced 2.84%	20,082 $1.8 Million
Q2 2024 Aug 08, 2024	BUY	$65.72 - $80.5 $53,430 - $65,446	813 Added 4.09%	20,668 $1.66 Million
Q1 2024 May 13, 2024	BUY	$69.39 - $97.64 $295,809 - $416,239	4,263 Added 27.34%	19,855 $1.58 Million
Q4 2023 Feb 13, 2024	SELL	$57.42 - $83.61 $19,867 - $28,929	-346 Reduced 2.17%	15,592 $1.24 Million
Q3 2023 Nov 13, 2023	BUY	$69.25 - $82.21 $208,304 - $247,287	3,008 Added 23.26%	15,938 $1.11 Million
Q2 2023 Aug 04, 2023	BUY	$58.41 - $90.35 $143,513 - $221,989	2,457 Added 23.46%	12,930 $929,000
Q1 2023 May 11, 2023	SELL	$58.39 - $75.0 $90,387 - $116,100	-1,548 Reduced 12.88%	10,473 $645,000
Q4 2022 Feb 07, 2023	SELL	$39.94 - $79.72 $110,234 - $220,027	-2,760 Reduced 18.67%	12,021 $927,000
Q3 2022 Nov 10, 2022	BUY	$36.06 - $69.85 $142,400 - $275,837	3,949 Added 36.46%	14,781 $660,000
Q2 2022 Aug 03, 2022	BUY	$21.74 - $46.75 $67,480 - $145,112	3,104 Added 40.17%	10,832 $415,000
Q1 2022 May 04, 2022	SELL	$23.7 - $41.39 $26,781 - $46,770	-1,130 Reduced 12.76%	7,728 $320,000
Q4 2021 Feb 04, 2022	SELL	$30.7 - $43.36 $101,555 - $143,434	-3,308 Reduced 27.19%	8,858 $335,000
Q3 2021 Oct 07, 2021	BUY	$19.91 - $68.26 $10,572 - $36,246	531 Added 4.56%	12,166 $401,000
Q2 2021 Aug 04, 2021	BUY	$50.63 - $73.5 $118,271 - $171,696	2,336 Added 25.12%	11,635 $785,000
Q1 2021 May 04, 2021	BUY	$55.91 - $81.44 $519,907 - $757,310	9,299 New	9,299 $527,000

Others Institutions Holding AXSM

# of Institutions

327

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.45B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Axsome Therapeutics, Inc. Transaction History